# TERPS (NCT05223803)

> TERPS Trial for de Novo Oligometastic Prostate Cancer

No report yet. It can be ordered.

## Registry

- Registry record: https://clinicaltrials.gov/study/NCT05223803
- Phase: PHASE2
- Status: RECRUITING
- Sponsor: University of Maryland, Baltimore
- Conditions: Prostate Cancer; Oligometastatic Disease
- Interventions: Prostate radiation (XRT); Systemic Therapy; Stereotactic ablative radiation therapy (SABR)
- Enrollment: 122
- Primary outcome: To determine the 2-year failure-free survival (FFS) of men who have oligometastatic prostate cancer with BST+XRT versus BST+XRT+SABR MDT.

## Indexed commentary on TERPS so far

Podcasts, YouTube videos and X posts we have indexed that name the trial. This is where a report starts, not where it ends: the build searches for more, so finished reports usually cover more than this.

- X threads: 9

## Order

Focused, $750, price fixed at order: https://www.erudio.com/contact?report=terps-nct05223803

## Free preview

POST https://www.erudio.com/api/trial-requests with {"nct_id": "NCT05223803", "email": "<work email>"}; the inbox owner confirms by the emailed link.